- Position of adjuvant therapy in the therapy of melanoma2018 | First Faculty of Medicine
- Adjuvant therapy for melanoma in real world2023 | Faculty of Medicine in Hradec Králové
- CDK4/6 inhibitors in adjuvant therapy of breast cancer2023 | First Faculty of Medicine
- Neoadjuvant and adjuvant therapy in the treatment of colorectal carcinoma2012 | First Faculty of Medicine
- Capecitabin e and oxaliplatin (XELOX) in adjuvant therapy of colorectal cancer. Results of the NO16968 (XELOXA) trial2010 | First Faculty of Medicine
- Adjuvant therapy of malignant melanoma: general and practical experience2021 | Faculty of Medicine in Hradec Králové
- Transtuzumab in adjuvant therapyPublication without faculty affiliation
- Adjuvant Therapy of the Renal Carcinoma2002 | First Faculty of Medicine
- The role of C-ERB-B2 expres test for adjuvant therapy of breast cancer.1999 | Faculty of Physical Education and Sport
- Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial2019 | First Faculty of Medicine
- Breast cancer - adjuvant therapy in 2000Publication without faculty affiliation
- Mifamurtide - a new approach to adjuvant therapy of osteosarcomas2013 | Second Faculty of Medicine
- News in adjuvant therapy for breast cancer2015 | First Faculty of Medicine
- Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy2008 | First Faculty of Medicine
- Cranberry and probiotics - prevention and adjuvant therapy of recurrent urinary tract infections2012 | Publication without faculty affiliation
- The comparative randomised study of adjuvant therapy of breast cancer patients with tamoxifen versus tamoxifen plus chemotherapy.1999 | Faculty of Physical Education and Sport
- Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma2017 | Faculty of Medicine in Pilsen
- Quality of life is an important factor in the indication in patients with advanced pancreatic carcinoma - a prospective multicentric study2012 | Publication without faculty affiliation
- Tamoxifen or Tamoxifen plus CMF in adjuvant therapy of breast cancer patient2001 | First Faculty of Medicine
- Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma2023 | First Faculty of Medicine, Second Faculty of Medicine
- Stratification of Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies2021 | Second Faculty of Medicine
- Osteosarcoma of the urinary bladder in a patient with prolonged adjuvant therapy, primarily prostate cancer2011 | Faculty of Medicine in Hradec Králové
- Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG)2021 | Second Faculty of Medicine
- The rol of high dose chemotherapy in the adjuvant therapy of high risk breast cancerPublication without faculty affiliation
- Adjuvant therapy of breast cancer. CMF orantracycline combination - result of multicentric studyPublication without faculty affiliation
- Ground-breaking ADAURA trial - osimertinib as adjuvant therapy of EGFR-mutated NSCLC2022 | First Faculty of Medicine
- Lapatinib in second line treatment of metastatic HER2+ breast cancer2012 | First Faculty of Medicine
- Natural compounds and structured biological systems in prevention and adjuvant therapy of infectious diseases of pigs +12007 | Publication without faculty affiliation
- Osteosarcoma of the urinary bladder in a patient after prolonged adjuvant therapy for primary urothelial bladder carcinoma2015 | Faculty of Medicine in Hradec Králové